FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308394426> ?p ?o ?g. }

• W4308394426 abstract "<h3>Background</h3> Myeloid cells are the most abundant immune cells within the tumor microenvironment (TME) where they play important roles regulating anti-tumor immunity. Targeting myeloid-specific inhibitory receptors to modulate the TME represents an attractive strategy to improve the therapeutic outcome of current cancer immune therapies. Siglec-10 is an inhibitory receptor expressed on tumor-associated macrophages (TAMs) and dendritic cells that regulates immune cell activation via immunoreceptor tyrosine-based inhibitory motifs. Recently, Siglec-10 was shown to induce immunosuppression and promote tumor immune escape through interaction with CD24. Similarly, CD52 and vascular adhesion protein-1 have been shown to drive immunosuppression via Siglec-10, indicating that Siglec-10 functions as an inhibitory receptor through multiple ligands. Here, we report that Siglec-10 expression is upregulated in human tumors and blockade of Siglec-10 with a monoclonal antibody (mAb) enhances proinflammatory responses and delays tumor growth in vivo by modulating myeloid cell function. <h3>Methods</h3> Siglec-10 expression was evaluated in human tumors by flow cytometry and RNA-sequencing. Anti-human Siglec-10 mAbs were generated using hybridoma technology and recombinantly produced on mouse IgG1 backbones. Internalization and function of Siglec-10 mAbs were evaluated in vitro by flow cytometry and cytokine production using isolated human CD16⁺ monocytes. To assess the in vivo activity of a Siglec-10 mAb, transgenic mice expressing Siglec-10 were generated and challenged with poly I:C. Anti-tumor activity of a Siglec-10 mAb was determined using the MC38 syngeneic mouse model. <h3>Results</h3> RNA-sequencing data revealed high expression of Siglec-10 across multiple tumors compared to normal tissues, including glioblastoma, colorectal carcinoma, and kidney renal clear cell carcinoma. Specifically, Siglec-10 was found to be highly and selectively expressed on intratumor dendritic cells and macrophages. Siglec-10 mAb treatment blocked ligand binding, induced complete receptor internalization, and significantly enhanced TLR-mediated human monocyte activation in vitro. Similarly, in vivo administration of a Siglec-10 mAb induced receptor internalization and enhanced TLR-mediated inflammation as evidenced by increased levels of cytokines, such as TNF and IL-12p40 (figure 1). To assess the potential of a Siglec-10 mAb as an anti-cancer immunotherapy, we established a colon carcinoma model in Siglec-10 transgenic mice. Siglec-10 mAb blockade polarized myeloid cells towards an inflammatory phenotype, enhanced adaptive immune cell activation and promoted anti-tumor activity. <h3>Conclusions</h3> Siglec-10 is highly expressed on tumor-associated myeloid cells and antibody blockade promotes anti-tumor immunity through activation of TAMs and dendritic cells. Our findings highlight Siglec-10 as a promising myeloid cell target for enhancing anti-tumor immunity in solid tumors. <h3>Ethics Approval</h3> All legal and ethical requirements have been met with regards to the humane treatment of animals described in this study." @default.
• W4308394426 created "2022-11-11" @default.
• W4308394426 creator A5001569412 @default.
• W4308394426 creator A5002862446 @default.
• W4308394426 creator A5004641141 @default.
• W4308394426 creator A5011444880 @default.
• W4308394426 creator A5028419995 @default.
• W4308394426 creator A5033234724 @default.
• W4308394426 creator A5049289797 @default.
• W4308394426 creator A5052229495 @default.
• W4308394426 creator A5068241354 @default.
• W4308394426 creator A5073966805 @default.
• W4308394426 date "2022-11-01" @default.
• W4308394426 modified "2023-09-25" @default.
• W4308394426 title "1396 Antibody blockade of the immunoinhibitory receptor Siglec 10 polarizes tumor associated myeloid cells and promotes anti-tumor immunity" @default.
• W4308394426 doi "https://doi.org/10.1136/jitc-2022-sitc2022.1396" @default.
• W4308394426 hasPublicationYear "2022" @default.
• W4308394426 type Work @default.
• W4308394426 citedByCount "0" @default.
• W4308394426 crossrefType "proceedings-article" @default.
• W4308394426 hasAuthorship W4308394426A5001569412 @default.
• W4308394426 hasAuthorship W4308394426A5002862446 @default.
• W4308394426 hasAuthorship W4308394426A5004641141 @default.
• W4308394426 hasAuthorship W4308394426A5011444880 @default.
• W4308394426 hasAuthorship W4308394426A5028419995 @default.
• W4308394426 hasAuthorship W4308394426A5033234724 @default.
• W4308394426 hasAuthorship W4308394426A5049289797 @default.
• W4308394426 hasAuthorship W4308394426A5052229495 @default.
• W4308394426 hasAuthorship W4308394426A5068241354 @default.
• W4308394426 hasAuthorship W4308394426A5073966805 @default.
• W4308394426 hasBestOaLocation W43083944261 @default.
• W4308394426 hasConcept C159654299 @default.
• W4308394426 hasConcept C203014093 @default.
• W4308394426 hasConcept C2776107976 @default.
• W4308394426 hasConcept C2777701055 @default.
• W4308394426 hasConcept C2778017598 @default.
• W4308394426 hasConcept C2779282312 @default.
• W4308394426 hasConcept C502942594 @default.
• W4308394426 hasConcept C542903549 @default.
• W4308394426 hasConcept C86803240 @default.
• W4308394426 hasConcept C8891405 @default.
• W4308394426 hasConcept C95444343 @default.
• W4308394426 hasConceptScore W4308394426C159654299 @default.
• W4308394426 hasConceptScore W4308394426C203014093 @default.
• W4308394426 hasConceptScore W4308394426C2776107976 @default.
• W4308394426 hasConceptScore W4308394426C2777701055 @default.
• W4308394426 hasConceptScore W4308394426C2778017598 @default.
• W4308394426 hasConceptScore W4308394426C2779282312 @default.
• W4308394426 hasConceptScore W4308394426C502942594 @default.
• W4308394426 hasConceptScore W4308394426C542903549 @default.
• W4308394426 hasConceptScore W4308394426C86803240 @default.
• W4308394426 hasConceptScore W4308394426C8891405 @default.
• W4308394426 hasConceptScore W4308394426C95444343 @default.
• W4308394426 hasLocation W43083944261 @default.
• W4308394426 hasOpenAccess W4308394426 @default.
• W4308394426 hasPrimaryLocation W43083944261 @default.
• W4308394426 hasRelatedWork W2001861465 @default.
• W4308394426 hasRelatedWork W2984962695 @default.
• W4308394426 hasRelatedWork W3025154575 @default.
• W4308394426 hasRelatedWork W3028822667 @default.
• W4308394426 hasRelatedWork W3125366473 @default.
• W4308394426 hasRelatedWork W3137351506 @default.
• W4308394426 hasRelatedWork W4286629873 @default.
• W4308394426 hasRelatedWork W4312075079 @default.
• W4308394426 hasRelatedWork W4313382728 @default.
• W4308394426 hasRelatedWork W4362003594 @default.
• W4308394426 isParatext "false" @default.
• W4308394426 isRetracted "false" @default.
• W4308394426 workType "article" @default.